154 related articles for article (PubMed ID: 33709175)
21. Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy.
Nieman DR; Peyre CG; Watson TJ; Cao W; Lunt MD; Lada MJ; Han MS; Jones CE; Peters JH
Ann Thorac Surg; 2015 Jan; 99(1):277-83. PubMed ID: 25442991
[TBL] [Abstract][Full Text] [Related]
22. Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma.
Goense L; van Rossum PSN; Xi M; Maru DM; Carter BW; Meijer GJ; Ho L; van Hillegersberg R; Hofstetter WL; Lin SH
Ann Surg Oncol; 2018 Jun; 25(6):1598-1607. PubMed ID: 29569125
[TBL] [Abstract][Full Text] [Related]
23. The impact of preoperative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma.
Bekkar S; Gronnier C; Messager M; Robb WB; Piessen G; Mariette C;
Ann Thorac Surg; 2014 Jan; 97(1):303-10. PubMed ID: 24200394
[TBL] [Abstract][Full Text] [Related]
24. The effect of histologic grade on neoadjuvant treatment outcomes in esophageal cancer.
Pointer DT; McDonald JA; Naffouje SA; Mehta R; Fleming JB; Fontaine JP; Lauwers GY; Frakes JM; Hoffe SE; Pimiento JM
J Surg Oncol; 2022 Sep; 126(3):465-478. PubMed ID: 35578777
[TBL] [Abstract][Full Text] [Related]
25. BMI-adjusted prognosis of signet ring cell carcinoma in patients undergoing radical gastrectomy for gastric adenocarcinoma.
Wang JB; Lin MQ; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Zheng CH; Huang CM
Asian J Surg; 2021 Jan; 44(1):116-122. PubMed ID: 32467008
[TBL] [Abstract][Full Text] [Related]
26. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
[TBL] [Abstract][Full Text] [Related]
27. Impact of response evaluation for resectable esophageal adenocarcinoma - a retrospective cohort study.
Bachmann R; Bachmann J; Hungbauer A; Schmehl J; Sitzmann G; Königsrainer A; Ladurner R
Int J Surg; 2014 Oct; 12(10):1025-30. PubMed ID: 25192805
[TBL] [Abstract][Full Text] [Related]
28. Signet ring cell mixed histology may show more aggressive behavior than other histologies in early gastric cancer.
Huh CW; Jung DH; Kim JH; Lee YC; Kim H; Kim H; Yoon SO; Youn YH; Park H; Lee SI; Choi SH; Cheong JH; Noh SH
J Surg Oncol; 2013 Feb; 107(2):124-9. PubMed ID: 22991272
[TBL] [Abstract][Full Text] [Related]
29. Esophageal adenocarcinoma stage III: Survival based on pathological response to neoadjuvant treatment.
Schwameis K; Zehetner J; Hagen JA; Oh DS; Worrell SG; Rona K; Cheng N; Samaan J; Green KM; Lipham JC
Surg Oncol; 2017 Dec; 26(4):522-526. PubMed ID: 29113673
[TBL] [Abstract][Full Text] [Related]
30. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.
Schölvinck D; Künzli H; Meijer S; Seldenrijk K; van Berge Henegouwen M; Bergman J; Weusten B
Surg Endosc; 2016 Sep; 30(9):4102-13. PubMed ID: 27357927
[TBL] [Abstract][Full Text] [Related]
31. Is signet-ring cell carcinoma a specific entity among gastric cancers?
Voron T; Messager M; Duhamel A; Lefevre J; Mabrut JY; Goere D; Meunier B; Brigand C; Hamy A; Glehen O; Mariette C; Paye F
Gastric Cancer; 2016 Oct; 19(4):1027-1040. PubMed ID: 26606931
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of IgG4+ plasma cell infiltrates following neoadjuvant chemoradiation therapy for esophageal adenocarcinoma.
Yakirevich E; Lu S; Allen D; Mangray S; Fanion JR; Lombardo KA; Safran H; Resnick MB
Hum Pathol; 2017 Aug; 66():126-135. PubMed ID: 28666927
[TBL] [Abstract][Full Text] [Related]
33. Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia.
Chon HJ; Hyung WJ; Kim C; Park S; Kim JH; Park CH; Ahn JB; Kim H; Chung HC; Rha SY; Noh SH; Jeung HC
Ann Surg; 2017 May; 265(5):946-953. PubMed ID: 27232252
[TBL] [Abstract][Full Text] [Related]
34. Impact of histology classification on pathologic treatment response and overall survival in distal esophageal cancer patients: a propensity matched analysis.
Saeed SM; Naffouje S; Mehta R; Hoffe SE; Fontaine JP; Lauwers GY; Shah P; Frakes J; Pimiento JM
Dis Esophagus; 2021 Aug; 34(8):. PubMed ID: 32996568
[TBL] [Abstract][Full Text] [Related]
35. Young Adults With Esophageal Adenocarcinoma Present With More Advanced Stage Tumors and Have Shorter Survival Times.
Sawas T; Manrique GC; Iyer PG; Wang KK; Katzka DA
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1756-1762. PubMed ID: 30267861
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis.
Ackermann CJ; Guller U; Jochum W; Schmied BM; Warschkow R
Int J Colorectal Dis; 2018 Sep; 33(9):1183-1193. PubMed ID: 29881972
[TBL] [Abstract][Full Text] [Related]
37. Signet ring cells in esophageal and gastroesophageal junction carcinomas have a more aggressive biological behavior.
Nafteux PR; Lerut TE; Villeneuve PJ; Dhaenens JM; De Hertogh G; Moons J; Coosemans WJ; Van Veer HG; De Leyn PR
Ann Surg; 2014 Dec; 260(6):1023-9. PubMed ID: 24836142
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological characteristics of signet ring cell carcinoma of the stomach.
Kim DY; Park YK; Joo JK; Ryu SY; Kim YJ; Kim SK; Lee JH
ANZ J Surg; 2004 Dec; 74(12):1060-4. PubMed ID: 15574148
[TBL] [Abstract][Full Text] [Related]
39. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
[TBL] [Abstract][Full Text] [Related]
40. Signet ring cell adenocarcinomas: different clinical-pathological characteristics of oesophageal and gastric locations.
Piessen G; Messager M; Lefevre JH; Goéré D; Mabrut JY; Meunier B; Brigand C; Hamy A; Glehen O; Mariette C;
Eur J Surg Oncol; 2014 Dec; 40(12):1746-55. PubMed ID: 25012732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
